ITPR1 and Alzheimer disease: This study is aimed at using Bcl-2-based strategies to counteract AD by exploiting Bcl-2′s ability to suppress the transmission of IP3R/RyR-driven Ca2+-dependent signals that are dysregulated in the AD.